Baidu
map

专利申请的十一大误区

2015-03-24 吴 强 武汉钢铁(集团)公司 知识产权报

随着近几年国家对知识产权的重视,国内的企业对专利在提升核心竞争力方面的作用有了进一步的认识,纷纷加强了专利工作,专利申请量大幅度增加,但是在专利代理过程中,笔者发现不少企业在专利申请过程中,仍存在误区,需要早日改进。误区一:自主研发的成果不申请专利就有知识产权。一些技术人员认为只要是自主创新,就有了自主知识产权。其实不然,专利是一种垄断权,自主研发的技术成果如果不申请专利,就得不到法律确认和保

随着近几年国家对知识产权的重视,国内的企业对专利在提升核心竞争力方面的作用有了进一步的认识,纷纷加强了专利工作,专利申请量大幅度增加,但是在专利代理过程中,笔者发现不少企业在专利申请过程中,仍存在误区,需要早日改进。

误区一:自主研发的成果不申请专利就有知识产权。

一些技术人员认为只要是自主创新,就有了自主知识产权。其实不然,专利是一种垄断权,自主研发的技术成果如果不申请专利,就得不到法律确认和保护。当他人盗用其研究成果时,因研发者对成果不具有专利权,得不到法律保护,就无法追究盗用者的法律责任。同时,在我国,专利申请采用的是先申请原则,具有创造性、新颖性和实用性的发明创造谁先申请了,专利就授予谁。因此,研发者如不及时申请,而被他人抢先申请并被授予专利权,研发者就无法追究他人的法律责任。这样的案例在中国可以说是数不胜数。

误区二:产品投入大规模生产后才申请专利。

在与发明人就申请专利的技术内容进行交流时,他们中有很多人都有这样的想法:这一技术方案还未投入生产,也没有产品问世,此时申请专利是为时过早,等产品大规模投入生产后再申请专利更合适。殊不知,这时已经晚了,即使你侥幸获得授权,专利也处在不稳定状态之中。此时如果你发现有人侵权并提起诉讼,侵权人则会以专利申请之日技术已经被公开为由进行抗辩。你不但打不嬴官司,而且以前为申请专利所花费的精力、时间、金钱统统付之东流。专利申请的基础不是已经在市场上存在的产品,也不一定是已经成型的产品。只要有了切实可行的想法,就可以着手申请文件的撰写了。

误区三:专利产品的改进不需再申请专利。

有部分发明人认为申请了一项专利后,就可“高枕无忧”,从而忽视了后期的继续研发工作,即使开发出了新产品或有了新改进,也不再申请专利。这种错误认识的后果不异于未申请专利。因为当他人对该产品有了改进并申请了专利,反过来就限制了原专利权人产品的更新换代,这就会导致原专利权人不经意间反而变成了侵权人。此时,原专利权人就丧失了自己的知识产权。

误区四:一项技术成果只能申请一类专利。

有部分发明人认为一项技术成果一次只能申请一类专利,即只能申请发明专利或只能申请实用新型专利或者只能申请外观设计专利。我国专利法规定的专利类型有三类:发明专利、实用新型专利及外观设计专利,一项产品发明可同时申请多种专利,技术方案也可以同时申请实用新型和发明专利。实用新型专利批得快,可尽快获得相应保护,通常需1年左右时间;发明专利则通常需2~5年审查批准时间。随着国家对知识产权程度的提高,专利审查批准的时间也相对缩短。从近两年的审查情况看,新型专利通常10个月左右即可授权;发明专利则需1年半左右。因此,对于一些重要的产品发明,若发明人只申请了发明专利,而此时他人“双管齐下”,同时申请发明专利和实用新型专利,那么他将先获得实用新型专利,拥有了产品的专利权。发明人若使用该产品,反而构成了侵权。

误区五:专利申请是保护技术成果的惟一方法。

这是因为很多人对技术成果保护的方法不太清楚。对技术成果的保护可以采用两种方式:申请专利通过法律加以保护和通过技术秘密由技术持有人自己加以保护,两者各有利弊。如果技术成果申请了专利,当别人侵权时可以通过法律的强制性制裁侵权人保护专利权人的利益;不利之处就是必须充分公开技术方案,公开到使这一领域的普通技术人员能通过公开的技术方案加以实施的程度,这就给别人提供了在此技术方案基础上进一步研发的机会。如果技术成果采用技术秘密加以保护,不用像申请专利那样公开技术方案,如果保护措施得当,别人难以了解。

它的弱点就是一旦因为技术持有人保护不力导致泄密或被他人窃取,就很难追究他人的责任。或者他人也开发出同样的技术并申请了专利,你再用这一技术就构成了侵权,此时无论从技术上还是市场上都将处于被动状态。因此技术成果持有人可以在专利保护和技术秘密保护两者之间加以权衡,选择合适的方式。对那些容易保密、他人难以知晓的技术成果可以采用技术秘密保护,可口可乐的配方就是如此,直到今天仍处于很好的保护之中。而对那些业内行家看一眼就明白、很难保密的技术成果最好采用专利保护。

误区六:得到了专利证书就获得了有效的专利权。

这是多数专利权人的普遍认识误区。在我国,国家知识产权局对实用新型和外观设计专利不进行实质审查,即使在你申请之前已经有人就相同的技术方案申请过相同的专利,你的申请仍可能会被批准。如果没有人提出异议,你的专利权会维持下去。一旦有人对你的专利提出无效宣告,那么你的专利会百分之百地被无效掉。也就是说你并没有取得有效的专利权。就发明专利而言,虽然国家知识产权局对它进行过实质审查,但谁也不能保证发明专利审查部门对世界范围内所有相关的文献资料都检索过。所以得到专利证书,并不代表你的专利是真正有效的专利,只是代表国家知识产权行政机关对该专利申请的批准。只有在你的专利有效期内没有人对你的专利提出无效宣告或者有人提出无效宣告但复审委员会经过复审后维持了你的专利权,此时你的专利才是真正有效的专利。

误区七:技术方案交待不清楚。

很多单位的发明人提交的专利申请文件非常简单,有的甚至只有几句话,技术方案完全没有交待清楚,这给专利代理人制作正式专利申请文件带来很大困难。要求发明人提供更多的技术方案时,他们会以技术保密为由回避,表明这些发明人没有把握好保密与公开的度。他们只是一味要求保密,害怕多透露一点技术信息,而恰恰忽视了公开不充分的问题。大量的案例表明,如果一件专利申请被审查员以技术方案公开不充分为由而发出审查意见通知书,则这件专利申请有98%的可能被驳回。这一点希望引起发明人的高度重视。

误区八:专利申请前不做任何检索。

有些发明人提交的专利申请文件没有做查新检索,对技术方案的新颖性如何不确定,根本不知道其技术方案有没有公开过或公开使用过,这也是我国技术人员的通病——信息检索和收集信息的能力极低。有调查机构对我国沿海某发达地区的科技人员进行过调查统计,发现这些地区有近一半的科研人员不知道或从未用过国外的科技报告、标准、专利等情报价值很高的文献。这也是我国科研项目的重复率大大高于发达国家的原因。国外有人统计,在一项新的技术或新的发明中,其中约90%的知识是通过各种文献信息而获得的,真正创造性的工作仅占10%左右。这里笔者想强调的是,就公开而言,全世界范围内的任何文献都可影响技术方案的新颖性。在美国,就曾经发生过一个孩子的涂鸦否定了一件发明专利新颖性的案例。就公开使用而言,只有国内的使用才影响技术方案的新颖性。也就是说,国外已经普遍使用过的东西,如果国内没有出现,各种文献也没有相关记载,那你就可以申请专利。这一点在将来的专利法修改中可能有所变动。可见,检索工作在专利申请中是非常重要的一环,如果他人已经就某一技术方案申请过专利或者在相关文献中公开,你没有做检索也去就这一技术方案申请专利,那只能是白白浪费时间、金钱和精力了。

误区九:先发表论文或成果鉴定再申请专利。

有些发明人取得研究成果后急于发表文章或成果鉴定,而没有想到先申请专利保护。因为发表文章或成果鉴定不可避免地要公开技术内容,使专利申请失去新颖性而得不到保护。笔者在专利代理过程中就曾遇到过某单位的一件极具市场前景的专利申请因过早发表学术文章而不得不放弃。

误区十:对专利缺乏有效的管理。

有些企业申请了很多专利,但无专人管理。专利文件之间有的互相冲突,有的已无市场价值还在交纳年费。有的专利权已经遭受侵犯但企业管理者对专利特征不了解,不能及时提起诉讼,还有的则是专利文书撰写的申请质量差,不能起到应该有的保护作用。

误区十一:、缺乏长远的专利战略规划,有计划地实施专利战略对企业来说非常重要。

首先,可以避免时间和精力的浪费。一些企业毫无目的的申请大量专利,结果导致授权率低,并产生大量的垃圾专利,浪费时间和精力。其次,可以突破国外企业的专利包围。一个企业应该对自己行业内的基本专利状况及外围专利状况有十分明确的认识,只有这样才能找到技术突破口,排除他人专利障碍,确立自己的专利优势,从而赢得市场竞争。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2016-01-12 medsic

    认识误区,才能成功申请专利!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2016-01-12 medsic

    认识误区,才能成功申请专利!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2016-01-12 medsic

    不错,

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2016-01-12 medsic

    感谢分享~~

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2015-07-09 飞翔9899

    例子很多,学习了

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]
    2015-04-17 MedSci客户端网友

    还没到这地部呵呵

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=56297, encodeId=ce3c5629eb6, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=162, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56298, encodeId=3a375629858, content=认识误区,才能成功申请专利!, beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56299, encodeId=19305629924, content=不错,, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56300, encodeId=b27c5630018, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=201, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=56301, encodeId=0b93563010e, content=感谢分享~~, beContent=null, objectType=article, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Tue Jan 12 11:37:00 CST 2016, time=2016-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=31803, encodeId=b2f73180324, content=例子很多,学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01621631568, createdName=飞翔9899, createdTime=Thu Jul 09 11:20:00 CST 2015, time=2015-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1704907, encodeId=29d61e04907bd, content=<a href='/topic/show?id=71742062668' target=_blank style='color:#2F92EE;'>#专利申请#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20626, encryptionId=71742062668, topicName=专利申请)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e7a30885975, createdName=zhangjingnwpu, createdTime=Sun Jul 19 18:52:00 CST 2015, time=2015-07-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=21301, encodeId=cb2f21301dd, content=还没到这地部呵呵, beContent=null, objectType=article, channel=null, level=null, likeNumber=151, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Fri Apr 17 11:32:00 CST 2015, time=2015-04-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308751, encodeId=b8ee1308e5192, content=<a href='/topic/show?id=aa7291842d9' target=_blank style='color:#2F92EE;'>#误区#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=91842, encryptionId=aa7291842d9, topicName=误区)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9a6357, createdName=xiangyuzhou971, createdTime=Thu Mar 26 01:52:00 CST 2015, time=2015-03-26, status=1, ipAttribution=)]

相关资讯

知识产权将从“云端”走向大众

原标题:知识产权将从“云端”走向大众 知识产权不再是曲高和寡,而将成为人人都要了解的一项技能。昨天举行的上海市知识产权联席会议部署了2015年知识产权工作,其中全力以赴做好市委关于加快建设具有全球影响力的科技创新中心成为重中之重。上海市副市长赵雯表示,知识产权是创新的保障,在全面提倡“大众创业、万众创新”的今天,知识产权将从“云端”走向大众。 尽管本市去年专利申请总量同比下降5.5%,但4

专利侵权判定原则-什么情况下会造成侵权

专利侵权判定原则中国知识产权保护体系采用双轨制,即行政保护和司法保护相结合。被侵权人可以把侵权人的侵权行为诉之于法院,也可以请求行政机关处理。行政程序并不是司法程序的前置程序。中国的司法体系采取二审终审制,大多数知识产权案件的一审法院为中级人民法院,我国于2014年底先后成立了三家知识产权法院(北京、广州、上海),日后的知识产权案件将由知识产权法院和中级法院共同管辖审理。一、如下情形,不视为侵犯专

专利与公益 他们这样寻求平衡

稿件来源:解放日报 印度 私权与公共健康博弈,明智选择后者 2012年,拜耳在印度的败诉,印度本土制药商Natco获得了拜耳药品——多吉美(Nexavar)的专利使用许可。Natco顺利生产其仿制药,并在印度境内进行出售,这使得印度民众以更廉价的方式享用上了这一高效药物,多吉美的价格从每盒28万卢比降至8800卢比,降幅达到97%。 尽管印度专利局的创世之举引起很大的争议,欧美发达国家

如何看懂—专利文献号

(一)专利文献号专利文献是指国家知识产权局按照法定程序公布的专利申请文件和公告的授权专利文件。专利文献种类是指国家知识产权局按照相关法律法规对发明、实用新型、外观设计专利申请在法定程序中予以公布或公告,由此产生的各种专利文献。专利文献号是指国家知识产权局按照法定程序,在专利申请公布和专利授权公告时给予的专利文献标识号码。特点一件专利申请形成的专利文献至始至终只能获得一个专利文献号;例如:发明专利申

医药生物领域--不能申请专利的情形

一、疾病的诊断和治疗方法 是指以有生命的人体或动物体为直接实施对象,进行识别、确定或消除病因或病灶的过程。 出于人道主义的考虑和社会伦理的原因,医生在诊断和治疗过程中应当有选择各种方法和条件的自由; 另外,这类方法直接以有生命的人体或动物体为实施对象,无法在产业上利用,不属于专利法意义上的发明创造,因此,疾病的诊断和治疗方法不能被授予专利权。 例如: 1.外科手术

案例介绍—医药生物领域的授权专利

1、用于实施疾病诊断和治疗方法的仪器或装置例如:诊断和治疗用的仪器设备或手术器械。案例:一种重叠覆盖椭球体的消融灶产生系统及方法(授权公告号 CN 100484491 C)一种治疗肛瘘的压力控制单向挂线器(授权公告号 CN 100581488 C)医用封堵器抗压能力测试装置(授权公告号 CN 102435501 B)一种多功能医用洗头装置(授权公告号 CN 203263699 U)一种手术撑开

Baidu
map
Baidu
map
Baidu
map